All news
From the Other Side of the Laboratory Door
28 September 2026After undergoing pancreatic cancer treatment, Pamela stepped inside the laboratory through VOICE-Ireland. She reflects on learning the science behi...
Funding Member Organisations to Make a Greater Impact Across Europe
28 September 2026DiCE’s 2026 operational grants and Wolfram Nolte Memorial Award offer Member Organisations flexible funding to strengthen patient-led work across...
Strengthening the Voice of Liver Cancer Patients: Welcoming the Croatian Rare Liver Foundation to DiCE
25 September 2026The Croatian Rare Liver Foundation has joined DiCE, strengthening the voice of people affected by liver cancer in Croatia. Its expertise in patient...
How US Drug Pricing Could Affect Access to Cancer Medicines in Europe
24 September 2026US drug pricing reforms could influence when and where cancer medicines reach European patients. Evidence remains inconclusive, but concerns over d...
When Every Month Matters, Innovation Must Reach Patients
24 September 2026Pamela reflects on the promise of daraxonrasib for people living with pancreatic cancer, the urgent need to turn scientific progress into timely an...
Clear Words Are Not Enough: What Patient-Friendly Communication Really Means
21 September 2026Clear words are only the beginning. Truly patient-friendly cancer communication considers timing, emotion, individual needs and understanding, help...
Learning Together to Improve Lives: Highlights from the 11th DiCE Masterclass 2026
27 July 2026The 11th DiCE Masterclass brought together patient advocates, healthcare professionals, and researchers to explore the latest advances in digestive...
Strengthening Patient Voices at WECAN Academy 2026
26 July 2026DiCE advocates joined more than 100 patient leaders from 34 countries at WECAN Academy 2026, gaining new advocacy skills, sharing European initiati...
Unlocking New Hope for Small Bowel Adenocarcinoma
26 July 2026A rare cancer that deserves more answers: progress from a Small Bowel Adenocarcinoma project                           Â...
KI-COMPASS: Using AI to Transform Follow-Up Care After Gastroesophageal Cancer
26 July 2026KI-COMPASS is exploring how artificial intelligence, wearable technology and clinical data can personalise follow-up care after gastroesophageal ca...